--Morgan Stanley Adjusts Price Target on Cytek Biosciences to $13 From $14, Maintains Equal-Weight Rating

--Morgan Stanley Adjusts Price Target on Cytek Biosciences to $13 From $14, Maintains Equal-Weight Rating

MT Newswires · 05/11/2023 05:39

Please log in to view news